KW

Kwangdong Healthbio Co., Ltd.

086220 | KO

Overview

Corporate Details

ISIN(s):
KR7086220001
LEI:
Country:
South Korea
Address:
충청북도 청원군 오창읍 양청송대길 39(송대리), 오창읍
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-04 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2025-05-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-03-25 00:00
AGM Information
정기주주총회결과
Korean 15.2 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.6 KB
2025-03-17 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 436.1 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 114.1 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 26.1 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 25.1 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.4 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 28.6 KB
2024-12-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2024-10-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2024-10-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-08-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 53.3 KB
2024-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 53.6 KB

Automate Your Workflow. Get a real-time feed of all Kwangdong Healthbio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kwangdong Healthbio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kwangdong Healthbio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany
FYB
Forte Biosciences, Inc. Logo
Clinical-stage biopharma developing FB102 for autoimmune diseases like celiac, vitiligo, & alopecia.
United States of America
FBRX
Fortress Biotech, Inc. Logo
Acquires, develops, and commercializes drugs for oncology, gene therapy, and rare diseases.
United States of America
FBIO
FRACTYL HEALTH, INC. Logo
Developing gut-targeted endoscopic and gene therapies for obesity and type 2 diabetes.
United States of America
GUTS
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy
FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan
4554
Fulcrum Therapeutics, Inc. Logo
Develops gene-modulating small molecule drugs for rare, genetically defined diseases.
United States of America
FULC
FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan
4881
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan
4538
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom
FUM

Talk to a Data Expert

Have a question? We'll get back to you promptly.